Betherapeutics
Founded 2023 · 5 employees on LinkedIn · 1 known investors
BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
Founders & leadership
P
PhilipChief Scientific Officer
Investors · 1
Frequently asked questions
- What does Betherapeutics do?
- BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
- Who are Betherapeutics's investors?
- Betherapeutics's investors include Moonstone Venture Capital.